VENICE, Fla., September 18, 2014 /PRNewswire/ -- Flameret (OTC:
FLRE) announced today that it will launch Cannasone™, a hemp cream
rich in CBD (cannabidiol) within about one week. The company
recently announced the launch of Cannadol™ (high CBD hemp oil) and
also confirmed that the company is now shipping orders for
Cannadol™
The skincare cream will be sold in 8oz bottles through its
wholly-owned subsidiary Royal Hemp Corporation. Each 8oz bottle of
Cannasone™ will be infused with 200mg of CBD (cannabidiol) derived
from industrial hemp. The company is currently restricting sales
geographically, to the United
States only. The product will be marketed through Royal Hemp
Corporation, the company's recently formed Colorado wholly-owned subsidiary.
A study published in September
2013 in the British Journal of Pharmacology detailed how
cannabinoids (CBD "cannabidiol is a cannabinoid) can
potentially play a role in the treatment of diseases.
Researchers looked at the impact of phytocannabinoids (plant
derived cannabinoids) on the epigenetic regulation of skin
differentiation genes. Further scientific studies are required.
Scientific and clinical studies continue to emphasize CBD's
potential (although unproven through scientific studies) as a
possible treatment for a wide range of conditions, including
rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain,
schizophrenia, PTSD, antibiotic-resistant infections, epilepsy and
other neurological disorders. CBD has demonstrated neuroprotective
and neurogenic effects, and its anti-cancer properties are
currently being investigated at several academic research centers
in the United States and
elsewhere. However, none of the statements regarding Cannasone™
or the potential therapeutic benefits of cannabidiol have been
evaluated by the FDA.
John Meredith, Chief Executive
Officer of Flameret, Inc. remarked, "We are thrilled that we can
deliver this news to the marketplace. Flameret already has an
exciting product available for sale in our high CBD hemp oil and we
are cautiously optimistic about the commercial potential of
Cannasone. We are now one of only a handful of companies in the
world selling hemp oil rich in CBD."
Mr. Meredith added, "We expect many calls from our shareholders
and investors throughout the world asking about sales estimates on
Cannasone™. Although we expect significant interest, we will not
provide any sales estimates at this time."
About Flameret
Flameret, Inc. has developed fire retardant products to suit a
wide range of applications. These products are marketed under the
brand names; Flameret, Flamex, Ultra Flamex and Impex. Flameret™
products are patented and held in the name of United American
Inc.
The company is also in the process of launching a new line of
products derived from industrial hemp. These products will be
marketed under a wholly-owned subsidiary of Flameret, Inc.
About Royal Hemp Corporation
Royal Hemp Corporation is a Colorado corporation which was created to
market and sell hemp based nutraceuticals, industrial products and
consumer goods in the United
States and throughout the world. All of the corporation's
products will be legal to sell in all states in the United States and in many countries
throughout the world.
The press release may contain "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such statements
include, but are not limited to, any statements relating to the
Company's development program and any other statements that are not
historical facts. Such statements involve risks and uncertainties,
including, but not limited to, those risks and uncertainties
relating to difficulties or delays in development, testing,
regulatory approval, production and marketing of the Company's
products, the uncertainty of patent protection for the Company's
intellectual property or trade secrets, and the Company's ability
to obtain additional financing. Such statements are based on
management's current expectations, but actual results may differ
materially due to various factors, including those risks and
uncertainties mentioned or referred to in this press release.
Contact: John Meredith:
jwsmeredith@aol.com
SOURCE Flameret, Inc.